(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate

(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate

CAS No.179324-87-9
APIIxazomib/Bortezomib

Product Description

  • Product Name : (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
  • MDL No. : MFCD10566030
  • Molecular Formula: C17H29BF3NO4
  • Molecular weight: 379.223
  • Other Names: (1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0]dec-4-yl]-1-butanamine trifluoroacetate (1:1); (1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0]dec-4-yl]butan-1-amine trifluoroacetate (1:1); (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate
  • Uses: An intermediate in the preparation of Ixazomib/Bortezomib

FAQ

A1: We are a manufacturer.

A2: Negotiate via email→ sign the contract →ship the good

A3: We have GMP certificate issued by Chinese NMPA, EIR letter issued by USFDA, GMP certificate issued by Korean MFDS, CEP certificate, etc.

A4: Our factory is managed by GMP, we have our own QC lab to test the material and APIs.

A5: We have compliant SOP as per GMP requirement and will be handled according to SOP.

A6: